Modulating MiR-350/Akt/mTOR/beclin1 signaling by nitazoxanide ameliorates bleomycin-induced pulmonary fibrosis in a wistar rat model
Life Sciences · 2026
DOI: 10.1016/j.lfs.2025.124166 ↗Kurz gefasst
Fachartikel in der Zeitschrift Life Sciences, 2026. Verfasst von Eman M Elbaz und 3 weiteren Autor:innen. Beteiligte Einrichtung: Biochemistry Department, Faculty of Pharmacy, Cairo University, Cairo, 11562, Egypt. Electronic address: Eman.el-baz@pharma.cu.edu.eg. Hauptthemen laut MEDLINE: Pulmonary Fibrosis, MicroRNAs, Thiazoles. Die Arbeit nennt 74 Literaturangaben.
Abstract (Originalsprache)
AIMS: Pulmonary fibrosis (PF) is a destructive, inflammatory intersectional lung disease that has lethal consequences. Autophagy, a cellular homeostasis sustaining system, has shown a vital function in PF progression. Nitazoxanide (NTZ) is a broad-spectrum antiprotozoal agent that exhibits anti-inflammatory, antiviral, and anti-fibrotic properties. This study explores the potential therapeutic effect of NTZ on bleomycin (BLM)-induced PF in rats and studies its impact on autophagy pathways. MATERIALS AND METHODS: Four groups of adult male Wistar rats: the control group, BLM group (intratracheal single dose of 5 mg/kg), BLM + NTZ (200 mg/kg/day, p.o., for 28 days) group, and BLM + wortmannin (WM) (15 μg/kg/day, i.v., for 28 days) group, where WM was used to validate the role of PI3K/Akt/mTOR signaling pathway in PF. KEY FINDINGS: BLM administration promoted extensive degenerative changes and distortion of lung architecture that were reversed by NTZ. BLM upregulated the miR-350, PI3K/Akt/mTOR pathway, transforming growth factor-β1 (TGF-β1), and Smad3 while reducing autophagy-related proteins; beclin1 and LC3B, and the anti-inflammatory interleukin-37 (IL-37) relative to the control group. BLM induced tissue inflammation and apoptosis, and increased TNF-α, IL-6, and caspase-3 relative to the control group. NTZ significantly alleviated BLM-induced collagen fiber deposition and PF, suppressed miR-350/Akt/mTOR signaling, TGF-β1, IL-6, TNF-α, caspase-3 expressions, upregulated IL-37, and elevated autophagy-related proteins relative to the BLM group. SIGNIFICANCE: This study demonstrates, for the first time, the potential role of miR-350 in PF, and reveals a potential therapeutic role for NTZ in ameliorating BLM-induced PF, presumably by modifying the miR-350/Akt/mTOR/beclin1 signaling.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Biochemistry Department, Faculty of Pharmacy, Cairo University, Cairo, 11562, Egypt. Electronic address: Eman.el-baz@pharma.cu.edu.eg.
- Biochemistry Department, Faculty of Pharmacy, Cairo University, Cairo, 11562, Egypt; The Ministry of Health and Population, Cairo, 12515, Egypt. Electronic address: yara.shawky.mohamed@std.pharma.cu.edu.eg.
- Zoology Department, Faculty of Women for Arts, Science and Education, Ain Shams University, 11757, Egypt. Electronic address: amina_abdelrahman@women.asu.edu.eg.
- Biochemistry Department, Faculty of Pharmacy, Cairo University, Cairo, 11562, Egypt. Electronic address: maha.abdelmonem@pharma.cu.edu.eg.
Zitieren
APA
Elbaz, E. M., Shawky, Y., Abdel Rahman, A. A. S., & Abdelmonem, M. (2026). Modulating MiR-350/Akt/mTOR/beclin1 signaling by nitazoxanide ameliorates bleomycin-induced pulmonary fibrosis in a wistar rat model. Life Sciences. https://doi.org/10.1016/j.lfs.2025.124166
Vancouver
Elbaz EM, Shawky Y, Abdel Rahman AAS, Abdelmonem M. Modulating MiR-350/Akt/mTOR/beclin1 signaling by nitazoxanide ameliorates bleomycin-induced pulmonary fibrosis in a wistar rat model. Life Sciences. 2026. doi:10.1016/j.lfs.2025.124166
BibTeX
@article{Elbaz2026,
author = {Elbaz, Eman M and Shawky, Yara and Abdel Rahman, Amina A S and Abdelmonem, Maha},
title = {Modulating MiR-350/Akt/mTOR/beclin1 signaling by nitazoxanide ameliorates bleomycin-induced pulmonary fibrosis in a wistar rat model},
journal = {Life Sciences},
year = {2026},
doi = {10.1016/j.lfs.2025.124166}
}
EUVIMED